
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5485831
[patent_doc_number] => 20090275596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Treatment of Neurodegenerative Disorders with Thiourea Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/410136
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6172
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12410136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410136 | Treatment of neurodegenerative disorders with thiourea compounds | Mar 23, 2009 | Issued |
Array
(
[id] => 5458693
[patent_doc_number] => 20090258845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Combination Dosage Forms and Therapies for Supporting Bone Health'
[patent_app_type] => utility
[patent_app_number] => 12/409090
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6184
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409090 | Combination dosage forms and therapies for supporting bone health | Mar 22, 2009 | Issued |
Array
(
[id] => 5404629
[patent_doc_number] => 20090239943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Nutraceutical composition and methods for its use'
[patent_app_type] => utility
[patent_app_number] => 12/382520
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1907
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239943.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382520
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382520 | Nutraceutical composition and methods for its use | Mar 17, 2009 | Abandoned |
Array
(
[id] => 6098055
[patent_doc_number] => 20110003873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'PHARMACEUTICAL COMPOSITION AND ITS USE IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CEREBROVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/920579
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5037
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003873.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920579 | Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases | Mar 2, 2009 | Issued |
Array
(
[id] => 5495317
[patent_doc_number] => 20090263345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Otic compositions for the treatment of infections of the internal and external ear in mammals'
[patent_app_type] => utility
[patent_app_number] => 12/380463
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4613
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263345.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380463 | Otic compositions for the treatment of infections of the internal and external ear in mammals | Feb 26, 2009 | Abandoned |
Array
(
[id] => 8063441
[patent_doc_number] => 20110245302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND LOSARTAN AND PROCESS FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/139673
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5357
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245302.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139673
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139673 | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same | Feb 12, 2009 | Issued |
Array
(
[id] => 5404574
[patent_doc_number] => 20090239888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation'
[patent_app_type] => utility
[patent_app_number] => 12/370397
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19002
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239888.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370397 | Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation | Feb 11, 2009 | Abandoned |
Array
(
[id] => 5374779
[patent_doc_number] => 20090312340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/370442
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20018
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370442 | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Feb 11, 2009 | Abandoned |
Array
(
[id] => 6026563
[patent_doc_number] => 20110054025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'USE OF A PENTACYCLIC TRITERPENE IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/935233
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4088
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935233 | USE OF A PENTACYCLIC TRITERPENE IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS | Feb 11, 2009 | Abandoned |
Array
(
[id] => 5527883
[patent_doc_number] => 20090197960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Method of Inhibiting Polyneuropathic Pain with 3-(2-Dimethylaminomethylcyclohexyl) Phenol'
[patent_app_type] => utility
[patent_app_number] => 12/364108
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5169
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364108
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364108 | Method of Inhibiting Polyneuropathic Pain with 3-(2-Dimethylaminomethylcyclohexyl) Phenol | Feb 1, 2009 | Abandoned |
Array
(
[id] => 5527781
[patent_doc_number] => 20090197858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'HYPERCHOLESTROLEMIA AND TENDINOUS INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/359695
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10323
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197858.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359695
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359695 | Hypercholestrolemia and tendinous injuries | Jan 25, 2009 | Issued |
Array
(
[id] => 5410694
[patent_doc_number] => 20090124593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their ExtraGenital Complications'
[patent_app_type] => utility
[patent_app_number] => 12/353320
[patent_app_country] => US
[patent_app_date] => 2009-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9641
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12353320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/353320 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their ExtraGenital Complications | Jan 13, 2009 | Abandoned |
Array
(
[id] => 5304224
[patent_doc_number] => 20090298876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 12/351447
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89311
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298876.pdf
[firstpage_image] =>[orig_patent_app_number] => 12351447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351447 | Modulators of ATP-binding cassette transporters | Jan 8, 2009 | Issued |
Array
(
[id] => 6202930
[patent_doc_number] => 20110065716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'HYDROXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/811957
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15495
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811957 | Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors | Jan 8, 2009 | Issued |
Array
(
[id] => 7687408
[patent_doc_number] => 20090176883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'TRPA1 Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/348064
[patent_app_country] => US
[patent_app_date] => 2009-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15824
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176883.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348064
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348064 | TRPA1 antagonists | Jan 1, 2009 | Issued |
Array
(
[id] => 5343403
[patent_doc_number] => 20090182053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'FENOFIBRIC ACID AMORPHOUS DISPERSION; METHOD OF MAKING; AND METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/335698
[patent_app_country] => US
[patent_app_date] => 2008-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5370
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12335698
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/335698 | FENOFIBRIC ACID AMORPHOUS DISPERSION; METHOD OF MAKING; AND METHOD OF USE THEREOF | Dec 15, 2008 | Abandoned |
Array
(
[id] => 7687452
[patent_doc_number] => 20090176839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/327922
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17998
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12327922
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/327922 | FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID | Dec 3, 2008 | Abandoned |
Array
(
[id] => 5502762
[patent_doc_number] => 20090163450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/276494
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10752
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163450.pdf
[firstpage_image] =>[orig_patent_app_number] => 12276494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/276494 | COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF | Nov 23, 2008 | Abandoned |
Array
(
[id] => 5546748
[patent_doc_number] => 20090156625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => ' Novel Use of a Nicotinic Receptor Agonist 156'
[patent_app_type] => utility
[patent_app_number] => 12/275464
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8985
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156625.pdf
[firstpage_image] =>[orig_patent_app_number] => 12275464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/275464 | Novel Use of a Nicotinic Receptor Agonist 156 | Nov 20, 2008 | Abandoned |
Array
(
[id] => 5271063
[patent_doc_number] => 20090074839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications'
[patent_app_type] => utility
[patent_app_number] => 12/274535
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8859
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12274535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/274535 | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications | Nov 19, 2008 | Abandoned |